Skip to main content
Clinical Trials/NCT01720082
NCT01720082UnknownPhase 3

Randomized Controlled Trial Comparing Single Incision Laparoscopic Appendectomy Versus Standard Three Port Appendectomy in a Selected Cohort of Patients

Associazione Chirurghi Ospedalieri Italiani1 site in 1 country300 target enrollmentStarted: March 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 3
Enrollment
300
Locations
1
Primary Endpoint
Morbidity and mortality

Study Overview

Brief Summary

Laparoscopic appendectomy (LA) is nowadays considered the gold standard in fertile women affected by uncomplicated appendicitis. The level of evidence for benefits from LA in this subgroup is high. Since the dissemination of single access surgery (no-scars surgery) ameliorated outcome has been supposed in these patients regarding post-operative pain, hospital stay and cosmetics results, and keeping the same safety as LA. This randomized controlled study is supposed to give answers to these questions.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
14 Years to 60 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age: 14-60
  • •American Society of Anesthesiologists (ASA) score: I-III
  • •absence of non-correctable coagulopathy (international normalized ratio >1,5, or platelet count <90 × 109/l).
  • •diagnosis: acute appendicitis with surgical indication

Exclusion Criteria

  • •Complicated appendicitis after exploration or previously diagnosed (CT)
  • •Psychical inability
  • •Pregnancy

Arms & Interventions

Single incision laparoscopic appendectomy

Active Comparator

Acute appendicitis with surgical indication

Intervention: Single incision laparoscopic appendectomy (Procedure)

Multiport Laparoscopic appendectomy

Active Comparator

Acute appendicitis with surgical indication

Intervention: Multiport laparoscopic appendectomy (Procedure)

Outcomes

Primary Outcomes

Morbidity and mortality

Time Frame: 30 days

Secondary Outcomes

  • Incision related morbidity(6 months)
  • Quality of life(6 months)
  • Post-operative pain score(3 days)
  • Operative time(1 day)
  • Cosmetic result(6 months)
  • Post-operative hospital stay(7 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Nereo Vettoretto

MD

Associazione Chirurghi Ospedalieri Italiani

Study Sites (1)

Loading locations...

Similar Trials